Short Interest in Danaher Co. (NYSE:DHR) Drops By 6.5%

Danaher Co. (NYSE:DHRGet Rating) was the recipient of a significant drop in short interest in October. As of October 31st, there was short interest totalling 3,910,000 shares, a drop of 6.5% from the October 15th total of 4,180,000 shares. Based on an average daily volume of 2,610,000 shares, the short-interest ratio is currently 1.5 days. Approximately 0.6% of the shares of the company are short sold.

Danaher Stock Down 2.5 %

Shares of NYSE DHR opened at $259.62 on Friday. The company has a quick ratio of 1.38, a current ratio of 1.78 and a debt-to-equity ratio of 0.41. Danaher has a 52 week low of $233.71 and a 52 week high of $331.68. The firm’s fifty day moving average is $262.83 and its 200 day moving average is $264.26. The company has a market cap of $188.99 billion, a price-to-earnings ratio of 28.69, a PEG ratio of 2.14 and a beta of 0.82.

Danaher (NYSE:DHRGet Rating) last issued its earnings results on Thursday, October 20th. The conglomerate reported $2.56 EPS for the quarter, topping the consensus estimate of $2.24 by $0.32. Danaher had a net margin of 21.65% and a return on equity of 18.33%. The company had revenue of $7.66 billion for the quarter, compared to the consensus estimate of $7.17 billion. During the same period in the previous year, the firm earned $2.39 earnings per share. The firm’s revenue for the quarter was up 6.0% on a year-over-year basis. On average, equities research analysts expect that Danaher will post 10.53 earnings per share for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, October 28th. Investors of record on Friday, September 30th were paid a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 0.39%. The ex-dividend date of this dividend was Thursday, September 29th. Danaher’s payout ratio is 11.05%.

Insider Transactions at Danaher

In other news, CFO Matthew Mcgrew sold 18,935 shares of Danaher stock in a transaction dated Friday, November 11th. The shares were sold at an average price of $274.72, for a total value of $5,201,823.20. Following the completion of the transaction, the chief financial officer now owns 29,634 shares in the company, valued at $8,141,052.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CFO Matthew Mcgrew sold 18,935 shares of the firm’s stock in a transaction that occurred on Friday, November 11th. The shares were sold at an average price of $274.72, for a total value of $5,201,823.20. Following the completion of the transaction, the chief financial officer now directly owns 29,634 shares in the company, valued at $8,141,052.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Alan G. Spoon sold 500 shares of the firm’s stock in a transaction that occurred on Tuesday, October 25th. The shares were sold at an average price of $252.93, for a total transaction of $126,465.00. Following the completion of the transaction, the director now owns 107,135 shares of the company’s stock, valued at $27,097,655.55. The disclosure for this sale can be found here. Insiders sold 29,530 shares of company stock worth $8,015,916 over the last quarter. Corporate insiders own 11.20% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in DHR. Advisor OS LLC increased its position in Danaher by 0.6% during the 2nd quarter. Advisor OS LLC now owns 6,253 shares of the conglomerate’s stock valued at $1,585,000 after purchasing an additional 37 shares during the period. American National Bank increased its position in Danaher by 31.9% during the 3rd quarter. American National Bank now owns 157 shares of the conglomerate’s stock valued at $41,000 after purchasing an additional 38 shares during the period. Stonebridge Capital Advisors LLC increased its position in Danaher by 9.7% during the 3rd quarter. Stonebridge Capital Advisors LLC now owns 428 shares of the conglomerate’s stock valued at $111,000 after purchasing an additional 38 shares during the period. Strengthening Families & Communities LLC increased its position in Danaher by 3.2% during the 2nd quarter. Strengthening Families & Communities LLC now owns 1,248 shares of the conglomerate’s stock valued at $364,000 after purchasing an additional 39 shares during the period. Finally, Journey Advisory Group LLC increased its position in Danaher by 2.5% during the 2nd quarter. Journey Advisory Group LLC now owns 1,648 shares of the conglomerate’s stock valued at $475,000 after purchasing an additional 40 shares during the period. 77.27% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have issued reports on DHR. KeyCorp dropped their target price on shares of Danaher from $345.00 to $325.00 and set an “overweight” rating for the company in a research report on Friday, July 22nd. Sanford C. Bernstein began coverage on shares of Danaher in a research report on Tuesday, August 16th. They set an “outperform” rating and a $340.00 target price for the company. UBS Group lifted their target price on shares of Danaher from $297.00 to $323.00 and gave the company a “buy” rating in a research report on Thursday, July 28th. Royal Bank of Canada dropped their target price on shares of Danaher from $318.00 to $302.00 and set an “outperform” rating for the company in a research report on Friday, October 21st. Finally, StockNews.com began coverage on shares of Danaher in a research report on Wednesday, October 12th. They set a “strong-buy” rating for the company. Two investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $312.50.

Danaher Company Profile

(Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

See Also

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.